Mexico’s Genomma Lab Internacional SAB de CVreported OTC sales up by 14.2% to MXN6.07bn ($314m) in 2018, as turnover improved at a double-digit rate in all three of its reporting regions.
The 14.2% growth rate had been thanks to “key trade initiatives implemented across the regions during 2018 to enhance point of sale execution and visibility,” the firm noted.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?